AbbVie (ABBV) Minority Interest (2020 - 2026)
AbbVie (ABBV) posted quarterly Minority Interest of $44.0 million for Q1 2026, up 4.76% year-over-year from $42.0 million in Q1 2025, and up 4.76% quarter-over-quarter from $42.0 million in Q4 2025.
AbbVie (ABBV) Minority Interest (2020 - 2026) Analysis & Trends
AbbVie (ABBV) has reported Minority Interest for 7 consecutive years, with $44.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Minority Interest rose 4.76% year-over-year to $44.0 million; the TTM figure through Mar 2026 stood at $44.0 million (up 4.76% YoY), while the FY2025 annual figure was $42.0 million, up 7.69% from the prior year.
- Minority Interest climbed to $44.0 million in Q1 2026 per ABBV's latest filing, from $42.0 million in the prior quarter.
- Across five years, Minority Interest topped out at $45.0 million in Q2 2025 and bottomed at $29.0 million in Q1 2023.
- Historically, Minority Interest has averaged $37.8 million across 5 years, with a median of $39.0 million in 2024.
- Annual changes were most pronounced in 2022 — Minority Interest soared 40.0% — and 2023, when it slipped 8.57%.
- AbbVie's Minority Interest stood at $33.0 million in 2022, then grew by 12.12% to $37.0 million in 2023, then rose by 5.41% to $39.0 million in 2024, then rose by 7.69% to $42.0 million in 2025, then rose by 4.76% to $44.0 million in 2026.
- Business Quant data shows ABBV's Minority Interest at $44.0 million in Q1 2026, $42.0 million in Q4 2025, and $43.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47.00 Mn |
| Mar 31, 2026 | 44.00 Mn |
| Dec 31, 2025 | 42.00 Mn |
| Sep 30, 2025 | 43.00 Mn |
| Jun 30, 2025 | 45.00 Mn |
| Mar 31, 2025 | 42.00 Mn |
| Dec 31, 2024 | 39.00 Mn |
| Sep 30, 2024 | 39.00 Mn |
| Jun 30, 2024 | 43.00 Mn |
| Mar 31, 2024 | 40.00 Mn |
| Dec 31, 2023 | 37.00 Mn |
| Sep 30, 2023 | 35.00 Mn |
| Jun 30, 2023 | 32.00 Mn |
| Mar 31, 2023 | 29.00 Mn |
| Dec 31, 2022 | 33.00 Mn |
| Sep 30, 2022 | 33.00 Mn |
| Jun 30, 2022 | 35.00 Mn |
| Mar 31, 2022 | 31.00 Mn |
| Dec 31, 2021 | 28.00 Mn |
| Sep 30, 2021 | 27.00 Mn |